Brain PET Scan: Clinical Trials

13 trials of Brain PET Scan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 terminated. 6 Phase 1, 5 Phase 2, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Terminated 1
Phase 25Completed 4, Terminated 1
Phase 32Completed 2
Early Phase 11Completed 1

Follow Brain PET Scan: new trials by email Literature Review of Brain PET Scan trials Research Report on Brain PET Scan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
flortaucipir F18, Brain PET Scan - Alzheimer Disease
Phase 3CompletedAvid Radiopharmaceuticals2052019-03-282020-08-28
Tau Screening Study in Subjects With Early Symptomatic AD
Flortaucipir F18, Brain PET Scan - Alzheimer Disease
Phase 2CompletedAvid Radiopharmaceuticals1612018-03-082020-08-24
Tau Screening Study in Patients With Early Symptomatic AD
Flortaucipir F18, Brain PET Scan - Alzheimer Disease
Phase 2CompletedAvid Radiopharmaceuticals1552017-11-212020-08-24
Flortaucipir PET Imaging in Subjects With FTD
Flortaucipir F18, Brain PET scan - Frontotemporal Dementia
Phase 1CompletedAvid Radiopharmaceuticals162017-04-112020-09-25
Flortaucipir 18F PET Imaging in BIOCARD Study
Flortaucipir F18, Brain PET scan - Cognitive Decline
Phase 1TerminatedAvid Radiopharmaceuticals232017-03-232020-09-25
Tau Imaging in Professional Fighters
Flortaucipir F18, Brain PET scan - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals352015-02-182020-09-10
Clinical Evaluation of Flortaucipir F 18
Flortaucipir F18, Brain PET scan - Alzheimer's Disease, Traumatic Brain Injury
Phase 2CompletedAvid Radiopharmaceuticals1792014-12-012020-09-10
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
Flortaucipir F18, Brain PET scan - Alzheimer Disease, Mild Cognitive Impairment
Phase 1CompletedAvid Radiopharmaceuticals892014-10-012020-09-25
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Flortaucipir F18, Brain PET scan - Progressive Supranuclear Palsy, Corticobasal Degeneration
Phase 1CompletedAvid Radiopharmaceuticals292014-08-122020-08-28
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
Flortaucipir F18, Florbetapir F 18, Brain PET Scan - Alzheimer's Disease
Phase 2TerminatedAvid Radiopharmaceuticals442014-05-012020-09-07
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
florbetapir F 18, Flortaucipir F18, Brain PET Scan - Alzheimer's Disease
Phase 2 / Phase 3CompletedAvid Radiopharmaceuticals3832013-12-012020-09-22
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
Flortaucipir F18, Brain PET scan - Alzheimer's Disease
Phase 1CompletedAvid Radiopharmaceuticals242013-11-132020-09-07
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
Flortaucipir F18, Brain PET Scan, Whole body PET scan - Alzheimer Disease
Early Phase 1CompletedAvid Radiopharmaceuticals362013-08-162020-09-25

Conditions studied

Alzheimer Disease (10)  ·  Cognitive Dysfunction (2)  ·  Brain Injuries, Traumatic (1)  ·  Corticobasal Degeneration (1)  ·  Depression (1)  ·  Frontotemporal Dementia (1)  ·  Supranuclear Palsy, Progressive (1)

Sponsors

Avid Radiopharmaceuticals (13)

Countries

United States (12)  ·  Canada (1)

Results publications

PMID 33587110, PMID 29284675, PMID 33141172, PMID 42467182